Shin Nippon Biomedical Laboratories, Ltd. (2395.T) JPX

1,110.00

+17(+1.56%)

Updated at June 03 12:58PM

Currency In JPY

Valuation

Market Cap58.87B
Enterprise Value81.59B
P/E Ratio10.08
PEG Ratio-1.39
Price/Sales Ratio1.42
Price/Book Ratio1.07
Enterprise/Revenue2.11
Enterprise/EBITDA9.05

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.07

Management Effectiveness

Return On Assets0.04
Return On Equity0.11

Income Statement

Revenue32.52B
Revenue/Share781.25
Gross Profit15.83B
EBITDA6.09B
Net Income4.57B
Diluted EPS109.69

Balance Sheet

Total Cash18.54B
Total Cash/Share445.24
Total Debt41.26B
Total Debt/Equity0.96
Current Ratio1.09
Book Value Per Share1,044.61

Price History

52-Week Change-17.59
52-Week High2,005
52-Week Low1,067
Moving Average 50 Days1,379.3
Moving Average 200 Days1,588.27

Statistics

Average Volume272,398
Shares Outstanding41.63M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield4.52
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 27, 2005